A systematic review of patient-reported outcome instruments of nonmelanoma skin cancer in the dermatologic population-Reference-Cited by-同舟云学术

A systematic review of patient-reported outcome instruments of nonmelanoma skin cancer in the dermatologic population

Published:2013-08 Issue:2 Volume:69 Page:e59-e67
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Lee Erica H.,Klassen Anne F.,Nehal Kishwer S.,Cano Stefan J.,Waters Janet,Pusic Andrea L.

Publisher

Elsevier BV

Subject

Dermatology

Reference43 articles.

1. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (US), Center for Biologics Evaluation and Research (US), Center for Devices and Radiological Health (US). Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims; 2009. Available from: URL:http://www.fda.gov/downloads/Drugs/.../Guidances/UCM193282.pdf. Accessed April 1, 2011.

2. Quality of life issues in nonmetastatic skin cancer;Burdon-Jones;Br J Dermatol,2010

3. Creation of a quality of life instrument for nonmelanoma skin cancer patients;Rhee;Laryngoscope,2005

4. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma;Chren;J Invest Dermatol,2007

5. Prospective study of long-term patient perceptions of their skin cancer surgery;Dixon;J Am Acad Dermatol,2007

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of Life in Patients Affected by Facial Basal Cell Carcinoma: Prospective Longitudinal Pilot Study and Validation of Skin Cancer Index in Lithuanian Language;Pragmatic and Observational Research;2024-08

2. Development and Validation of the Oxford Skin Cancer Treatment Scale, a Patient-Reported Outcome Measure for Health-Related Quality of Life and Treatment Satisfaction After Skin Cancer Treatment;Dermatologic Surgery;2024-07-12

3. Efficacy, tolerability, and quality of life evaluation in six patients affected by Gorlin-Goltz syndrome and treated with vismodegib 150 mg/die: a retrospective monocentric cohort analysis;Italian Journal of Dermatology and Venereology;2024-07

4. Neoadjuvant Photodynamic Therapy: An Updated Therapeutic Approach for Non-Melanoma Skin Cancers;Current Treatment Options in Oncology;2024-05-18

5. FACE-Q for Measuring Patient-reported Outcomes after Facial Skin Cancer Surgery: Cross-cultural Validation;Plastic and Reconstructive Surgery - Global Open;2024-04